Sun Pharmaceutical Industries has scheduled January 31 as the date for announcing its financial performance for the quarter ending December 2021 (Q3FY22).
The Company will conduct an hour-long call at 06.30 pm IST on January 31, 2022, where senior management will discuss the Company’s performance and answer questions from participants.
On Wednesday, the company's stock was under pressure. At around 10.49 am, Sun Pharma was performing at Rs836.80 per piece down by 1.08%.
The stock has touched an intraday high and low of Rs846.15 per piece and Rs834.05 per piece respectively.
In the September 2021 quarter (Q2FY22), Sun Pharma reported a 12.54% yoy rise in total revenues on a consolidated basis at Rs9,626cr. The consolidated Profit after tax (PAT) was up by 12.92% yoy at Rs2,047cr as most of the operating cost items including the raw material costs remained stable during the quarter.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.